US Stock MarketDetailed Quotes

ZNTL Zentalis Pharmaceuticals

Watchlist
  • 3.090
  • -0.040-1.28%
Close Dec 13 16:00 ET
  • 3.100
  • +0.010+0.32%
Post 17:41 ET
220.21MMarket Cap-1.24P/E (TTM)

About Zentalis Pharmaceuticals Company

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. The company was founded by Kevin D. Bunker and Cam Gallagher on December 23, 2014 and is headquartered in San Diego, CA.

Company Profile

SymbolZNTL
Company NameZentalis Pharmaceuticals
Listing DateApr 3, 2020
Issue Price18.00
Founded2014
CEOMs. Julie M. Eastland
MarketNASDAQ
Employees168
Fiscal Year Ends12-31
Address10275 Science Center Drive,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-263-4333
Websitehttp://www.zentalis.com

Company Executives

  • Name
  • Position
  • Salary
  • Julie M. Eastland
  • Chief Executive Officer, President and Director
  • --
  • Dr. Kyle Rasbach, PhD,Pharm.D.
  • Chief Business Officer
  • --
  • Andrea Paul
  • Chief Legal Officer and Corporate Secretary
  • 2.63M
  • Dr. Mark Lackner, PhD
  • Chief Scientific Officer
  • --
  • Dr. Diana F. Hausman, M.D.
  • Chief Medical Officer
  • 906.98K
  • Vincent Vultaggio
  • Principal Accounting Officer and Interim Principal Financial Officer
  • --
  • Scott D. Myers
  • Chairman of the Board
  • --
  • David M. Johnson
  • Chairman of the Board
  • 617.78K
  • Dr. Luke Nathaniel Walker, M.D.
  • Director
  • --
  • Dr. Jan Skvarka, PhD
  • Independent Director
  • 515.22K
  • Karan S. Takhar
  • Independent Director
  • --
  • Dr. Enoch Kariuki, Pharm.D.
  • Independent Director
  • 516.97K
Heat List
US
Overall
Symbol
Price
% Chg

No Data